Skip to main content

24 December 2025

Last updated: Wednesday 24 December 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Measuring how drugs bind to their targets

Friday 10 April 2015

Interviewee/Contributor

Michael Dabrowski

Organisation

Pelago Bioscience AB

Organisations

apceth GmbH & Co KG
Innate Pharma SA
argenx SE
Oslo Cancer Cluster, Radforsk
Novacta Biosystems Ltd
European Biopharmaceutical Enterprises
Strategus
Sofinnova Partners
4D pharma Plc
Forbion Capital Partners

Interviewees and Contributers

Graeme Martin
Matthias Kramer
Ingmar Hoerr
Robert Habib
Geert Walther Nygaard
Victoria English and Jean-Claude Muller
Miguel Forte
Duncan Peyton
Roger Pertwee
David Berman and Marcel Zwaal

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form